EP3061445
Lyfjaform í afar háum styrkleika.
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
10.9.2010EP published:
5.7.2023EP application number:
16156236.8
EP translation filed:
23.8.2023Grant published:
15.9.2023EPO information:
European Patent Register
Max expiry date:
9.9.2030Expiry date:
9.9.2026Next due date:
30.9.2026
Title in English:
HIGHLY CONCENTRATED PHARMACEUTICAL FORMULATIONSLanguage of the patent:
English
Timeline
Today
10.9.2010EP application
5.7.2023EP Publication
23.8.2023Translation submitted
15.9.2023Registration published
9.9.2026Expires
Owner
Name:
F. Hoffmann-La Roche AGAddress:
Grenzacherstrasse 124, 4070 Basel, CH
Inventor
Name:
ADLER, MichaelAddress:
4125 Riehen, CH
Name:
MAHLER, Hanns-ChristianAddress:
4001 Basel, CH
Name:
STAUCH, Oliver BorisAddress:
79102 Freiburg, DE
Agent
Name:
Lára Helga SveinsdóttirAddress:
Grundarstíg 23, 101, Reykjavík,
Priority
Number:
09170110Date:
11.9.2009Country:
EP
Classification
Categories:
A61P 35/00, A61P 37/02, A61P 43/00, A61K 9/19, A61K 47/10, A61K 47/26, A61K 38/47, A61K 9/00, A61K 47/18, A61K 47/20
Annual fees
Number
Paid
Expires
Payer
Number: 14
Paid: 15.9.2023
Expires: 9.9.2024
Payer: Árnason Faktor ehf.
Number: 15
Paid: 22.8.2024
Expires: 9.9.2025
Payer: Árnason Faktor ehf.
Number: 16
Paid: 10.9.2025
Expires: 9.9.2026
Payer: Árnason Faktor ehf.